Menu

Nosing Around

Covering neuroscience research means choosing from an embarrassment of riches.

Nov 1, 2016
Mary Beth Aberlin

ANDRZEJ KRAUZEBananas. That’s what I thought I was when I realized that I couldn’t smell the fruit’s unique odor. Nor could I smell the obviously soured milk in my refrigerator or the exhalations of smokers on the city sidewalks. Gourmet meals were now wasted on me, where once I had loved teasing apart their flavors. This affliction went on for months, long enough for me to seek medical help, which ruled out anything awful but offered no cure. Only much later, after a course of antibiotics taken for something else, did my sense of smell return.

So why am I telling you this? Every November, The Scientist focuses on neuroscience, and we pick out some new and exciting developments in the field to zero in on. In choosing this year’s cover, we turned again to the artwork of Greg Dunn, a former neuroscientist whose stunning painting of pyramidal neurons graced our November 2013 cover. When looking through Dunn’s portfolio, his print of cell connections in an olfactory bulb glomerulus hit a nerve, so to speak. It reminded me of my bout of anosmia (not to mention our October 2013 issue devoted to olfaction research).

For this month’s issue, Notebook section editor Bob Grant had assigned two articles related to altered senses of smell. The first, by Senior Editor Kerry Grens, took me right back to my own period of odor disturbance. She describes a serendipitously discovered treatment for smell restoration that involves sniffing a collection of aromatic oils. After weeks of this therapy, the sense of smell reappears for some 30 percent of people. How it works remains unclear, but the potential for recovery likely relates to the constant regeneration of sensory neurons in the nose.

In another twist on olfactory neuronal plasticity, Senior Editor Jef Akst reports on research showing that male mice continually exposed to the scent of female urine change their behavior toward females, seemingly as a result of losing a male-specific subset of neurons from their odor-processing organ. Coincidentally, those researchers monitored the changes in the neuron population using light-sheet microscopy, a technology that is the subject of one of this month’s Lab Tools.

As always, neuroscience is a gold mine of interesting research. One intriguing component of neural health is the role of diverse immune cells. Contrary to the long-held belief that the central nervous system is sheltered from the body’s immune system except in response to injury, researchers now recognize that T cells, macrophages, and other defenders reside in the brain and spinal cord, affecting not only pathogen defense, but also behavior, learning, and memory. Amanda Keener (“Immune System Maintains Brain Health”) reports on the good-cop role played by these immune cells and what happens when they go rogue.

Other neuro research covered in this issue includes a technique called MAP-seq, which uses mRNA barcoding to rapidly track single neuron pathways over long distances in the brain; a newly discovered neural network involved in the control of breathing; and findings about synaptic vesicles’ ability to release their contents even in the absence of a structural network at the axon’s end. There is also a profile of University of Pennsylvania neuroscientist Amita Sehgal, who studies the genes that regulate circadian and sleep rhythms (here); a Scientist to Watch article about olfactory researcher Jason Castro of Bates College; and a Foundations description of the invention of two-photon microscopy.

I look forward to nosing around the annual Society for Neuroscience meeting later this month. With a cast of tens of thousands and mountains of new research being unveiled, the conference is always an exciting way to discover what’s grabbing neuroscientists’ attention (and a sneak peek at what you’ll be reading in future issues of The Scientist). 

Mary Beth Aberlin   Editor-in-Chief
 

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.